NovaBridge Biosciences. ADR [NBP] stock prices are up 5.09% to $3.92 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NBP shares have gain 5.38% over the last week, with a monthly amount drifted -5.08%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
NovaBridge Biosciences. ADR [NASDAQ: NBP] stock has seen the most recent analyst activity on October 03, 2025, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $9. Previously, BTIG Research started tracking the stock with Buy rating on September 09, 2025, and set its price target to $7. On December 09, 2021, Siebert Williams Shank initiated with a Buy rating and assigned a price target of $96 on the stock. Daiwa Securities started tracking the stock assigning a Buy rating. Needham initiated its recommendation with a Buy and recommended $75 as its price target on March 15, 2021. H.C. Wainwright reiterated a Buy rating for this stock on March 03, 2021, and upped its price target to $75. In a note dated February 25, 2021, Piper Sandler initiated an Overweight rating and provided a target price of $75 on this stock.
The stock price of NovaBridge Biosciences. ADR [NBP] has been fluctuating between $0.60 and $6.79 over the past year. Currently, Wall Street analysts expect the stock to reach $7.75 within the next 12 months. NovaBridge Biosciences. ADR [NASDAQ: NBP] shares were valued at $3.92 at the most recent close of the market. An investor can expect a potential return of 97.7% based on the average NBP price forecast.
Analyzing the NBP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.11 and Total Capital is -0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that NovaBridge Biosciences. ADR [NASDAQ:NBP]’s Current Ratio is 14.47. Further, the Quick Ratio stands at 14.47, while the Cash Ratio is 14.17.
Transactions by insiders
Recent insider trading involved Skelton Joseph W., Officer, that happened on Jan 02 ’26 when 0.12 million shares were purchased. CHIEF MEDICAL OFFICER, Dennis Phillip Andrew completed a deal on Dec 18 ’25 to buy 3431.0 shares.
